WASHINGTON, Oct. 3 -- Food and Drug Administration has issued a notice called: Teva Branded Pharmaceutical Products R&D, Inc, et al.; Withdrawal of Approval of 39 New Drug Applications; Correction.
The notice was published in the Federal Register on Oct. 3 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Registeron August 4, 2025 (90 FR 36440). The document announced the withdrawal of approval of 39 new drug applications (NDA) from multiple applicants, withdrawn as of September 3, 2025. The document erroneously included NDA number 021290. The correct NDA number is 020212 for Zinecard (dexrazoxane h...